MDG Molecular Diagnostics Group GmbH is the competence network of the biotechnologically and pharmaceutically oriented companies Biotype GmbH, ROTOP Pharmaka GmbH and qualitype GmbH.
- MDG Molecular Diagnostics Group
- +49 351 8838 200
- info@mdx-group.com
Foundation: 2000
300 Employees
Locations
- Moritzburger Weg 67, 01109 Dresden
The three high-tech companies join forces in MDG to develop customized, cost-effective diagnostic and therapeutic solutions for precision medicine with few side effects and to promote their widespread application. Our approximately 300 highly specialized employees work together on innovative developments in precision medicine in order to make their pioneering application possible for as many patients as possible.
Firstly, the focus is on maximum efficiency in molecular diagnostics: to this end, BIOTYPE has developed the MODAPLEX system, a laboratory device for the automated multi-gene analysis of molecular biomarker signatures. Secondly, with ROTOP Pharmaka we are pursuing targeted theranostics with radioisotopes. It combines imaging diagnostics down to the molecular level of a tumor with the targeted therapy of precisely these tumor cells. And thirdly, with qualitype, we are focusing on consistent digitalization and data integration in the healthcare sector.
